Complete Spinal Cord Injury: A Realistic Prognosis and What Can Still Be Treated

Communication is key. I'd suggest two things: topic-oriented sessions on one specific subject at a time — lumbar spine surgery, or brain tumours — where everyone shares experience and problems and we learn from each other, since doctors from Africa and India face similar socioeconomic challenges. And continuous feedback after a patient returns home: the local doctor monitors recovery and communicates with us on repeat imaging and medication adjustments. That collaboration, by WhatsApp or email at any time, directly improves outcomes.

For intractable epilepsy, we prefer other surgical methods first — removing an identified lesion (medial temporal lobectomy, or hemispherectomy in appropriate cases). If no focus is identifiable and epilepsy remains uncontrolled, electrodes can be placed in the anterior thalamus, with roughly 70 to 80% success; vagal nerve stimulation is the alternative. For psychiatric disorders we have done some frontal DBS placements, but results are variable, the procedures are not curative, and patients still need to continue medication.

The main issues over time are battery depletion (non-rechargeable batteries need changing every 5 to 7 years, rechargeable systems last around 15 years), electrode disconnection or failure from trauma or mechanical wear, and the need for settings adjustments as the disease progresses. Patients need periodic visits for reprogramming, though newer devices allow remote setting changes via mobile. Battery change is the most common long-term issue.

We always start with medication at a lower dose, increasing gradually to control symptoms. The ideal time to move to DBS is around 4 to 5 years after diagnosis, when the required dose is becoming too high, side effects are a problem, or the medication effect is fading — DBS at that stage can abolish or significantly reduce the drug requirement and restore quality of life. At our hospital, the total package including surgery, anaesthesia, device, medicines, testing and hospital stay runs approximately USD 30,000 to 35,000, with the variation depending on rechargeable versus non-rechargeable devices.

For spine surgery, major complications run around 2%, life-threatening complications around 0.5%, and neurological deficit around 1 to 1.5% — 98% of patients do well, 90% do very well, at a centre doing 400 to 500 spine surgeries a year. Patients should understand that surgery corrects the structural problem but can't always undo pre-existing nerve damage, so some residual tingling or numbness may persist even in a good outcome. For brain surgery, mortality is around 1 to 2% and total risk of neurological deficit is 5 to 7% at expert centres, with 93% of patients doing very well after tumour removal — the main caveat is that malignant tumours can recur despite surgery, since resection alone isn't curative and radiotherapy and chemotherapy are also required.

No. A complete spinal cord injury will not result in complete motor recovery.

Baclofen or morphine pump implantation for spasticity, and dorsal cord stimulators for pain and sensation, which can also help some patients with incomplete injuries regain leg power when combined with physiotherapy.

Yes. Incomplete injuries carry a better outlook, with some patients regaining leg power through dorsal cord stimulation combined with physiotherapy, while complete injuries do not see meaningful motor recovery.

A trial of iliac bone-derived stem cells implanted at the injury site in around 20 patients found no statistically significant benefit and was discontinued. Stem cell therapy for complete spinal cord injury remains unrecommended anywhere in the world, though it may hold some promise for partial injuries.